Dyne Therapeutics, Inc.DYNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+40.8%
5Y CAGR+54.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+40.8%/yr
vs +140.3%/yr prior
5Y CAGR
+54.5%/yr
Recent deceleration
Acceleration
-99.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
8.8x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $398.33M | +41.6% |
| 2024 | $281.41M | +33.5% |
| 2023 | $210.76M | +47.6% |
| 2022 | $142.76M | +17.7% |
| 2021 | $121.31M | +168.4% |
| 2020 | $45.20M | +309.4% |
| 2019 | $11.04M | +158.1% |
| 2018 | $4.28M | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |